Learn More
Table 1: DALYs for Health Services Districts by proportions of total, proportions male, proportions due to premature mortality and proportion experienced by Indigenous Australians, Queensland, 2003 …………………..… 4 Table 2: Life expectancy, HALE, and proportion of life expectancy lost due to disability by Health Service District,
Current treatment of diffuse-large-B-cell lymphoma (DLBCL) includes rituximab, an expensive drug, combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy. Economic models have predicted rituximab plus CHOP (RCHOP) to be a cost-effective alternative to CHOP alone as first-line treatment of DLBCL, but it remains unclear(More)
  • 1